Merit Medical’s Temno Elite Soft Tissue Biopsy System Launched in the United States

September 27, 2022—Merit Medical Systems, Inc. announced the commercial launch of the Temno Elite soft tissue biopsy system in the United States.

According to the company, the Temno Elite device is indicated for use in various soft tissue locations—such as liver, lung, lymph nodes, kidney, and other soft tissue suspect lesions.

The company noted that with biopsies, where adequate sample size and quality are paramount for accurate diagnosis and treatment, the Temno Elite’s Total Core biopsy technology obtains samples 72% larger than side-notch, semiautomatic devices.

For procedure control, the device’s Sample Assist feature simplifies tissue removal, allowing clinicians to retrieve full samples with an easy slide of a button. An optional, valved coaxial introducer enhances patient safety by reducing the risk of air entry and fluid leakage, which is particularly important during lung biopsy.

“The sample quality of the Temno Elite is excellent,” commented Stuart Aronson, MD, in Merit Medical’s press release. “The cores are noticeably and consistently larger than other devices. The valved coaxial introducer reduces procedural steps and blood leakage and helps to reduce the risk of pneumothorax and air embolism.” Dr. Aronson is a diagnostic radiology specialist at Texas Health Harris Methodist Hospital in Fort Worth, Texas.

The single-use Temno Elite system complements the company’s biopsy device portfolio, which includes the Temno, Achieve, and Tru-Cut families of devices, noted Merit Medical.